| The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis | European Urology | 2008 | 561 |
| Tissue-engineered buccal mucosa urethroplasty-clinical outcomes | European Urology | 2008 | 165 |
| Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum | European Urology | 2008 | 130 |
| Decellularization and sterilization of porcine urinary bladder matrix for tissue engineering in the lower urinary tract | Regenerative Medicine | 2008 | 111 |
| British Society for Sexual Medicine guidelines on the management of erectile dysfunction | Journal of Sexual Medicine | 2008 | 98 |
| iTRAQ-facilitated proteomic analysis of human prostate cancer cells identifies proteins associated with progression | Journal of Proteome Research | 2008 | 95 |
| Height and prostate cancer risk: a large nested case-control study (ProtecT) and meta-analysis | Cancer Epidemiology Biomarkers and Prevention | 2008 | 80 |
| Surgical techniques in substitution urethroplasty using buccal mucosa for the treatment of anterior urethral strictures | European Urology | 2008 | 79 |
| Promoter hypermethylation in circulating blood cells identifies prostate cancer progression | International Journal of Cancer | 2008 | 66 |
| BMP-6 over-expression in prostate cancer is associated with increased Id-1 protein and a more invasive phenotype | Journal of Pathology | 2008 | 51 |
| Cholinergic innervation and muscarinic receptors in the human prostate | European Urology | 2008 | 48 |
| A comparison of the performance of microsatellite and methylation urine analysis for predicting the recurrence of urothelial cell carcinoma, and definition of a set of markers by Bayesian network analysis | BJU International | 2008 | 44 |
| Decision-making about PSA testing and prostate biopsies: a qualitative study embedded in a primary care randomised trial | European Urology | 2008 | 38 |
| Spontaneous contractions of the pig urinary bladder: the effect of ATP-sensitive potassium channels and the role of the mucosa | BJU International | 2008 | 31 |
| Diagnosis and treatment of lower urinary tract symptoms suggestive of overactive bladder and bladder outlet obstruction among men in general practice in the UK | International Journal of Clinical Practice | 2008 | 30 |
| Management of advanced prostate cancer: can we improve on androgen deprivation therapy? | BJU International | 2008 | 27 |
| Associations of lower urinary tract symptoms with prostate-specific antigen levels, and screen-detected localized and advanced prostate cancer: a case-control study nested within the UK population-based ProtecT (Prostate testing for cancer and Treatment) study | BJU International | 2008 | 26 |
| Management of the failure of a permanently implanted urethral stent-a therapeutic challenge | European Urology | 2008 | 19 |
| Urodynamics in the management of female stress incontinence--which test and when? | Current Opinion in Urology | 2008 | 19 |
| Definition of normality of pressure-flow parameters based on observations in asymptomatic men | Neurourology and Urodynamics | 2008 | 16 |
| Medical management of lower urinary tract symptoms in men: current treatment and future approaches | Nature Reviews Urology | 2008 | 14 |
| Laparoscopic nephro-ureterectomy for upper tract urothelial cancer: cystoscopic closed system pluck | Annals of the Royal College of Surgeons of England | 2008 | 5 |
| Old and New Urinary Markers: Which One is the PSA for Bladder Cancer? | European Urology Supplements | 2008 | 3 |
| Urological diagnosis – history and investigations | Surgery | 2008 | |
| What are the practitioner-level determinants for inappropriate PSA testing? | Nature Reviews Urology | 2008 | |
